Validation of an MPS based intestinal cell culture model for the evaluation of drug-induced toxicity

Stefanie Hoffmann,Philip Hewitt,Isabel Koscielski,Dorota Kurek,Wouter Strijker,Kinga Kosim

DOI: https://doi.org/10.1101/2024.07.18.604106

2024-07-22

Abstract:The potential for drug-induced gastrointestinal (GI) toxicity is significant, since the GI tract is one of the first barriers which come in to contact with oral drugs. In pharmaceutical research, the complex behavior of human intestinal cells is traditionally investigated using 2D cultures, in which one cell type grows under static conditions. With the development of advanced microphysiological systems (MPS) more in vivo like conditions can be generated which increase the physiological nature and also the predictive validity of these models. Caco-2 cells are known for their capability to build tight junctions. These connections are responsible for the maintenance of intestinal homeostasis and can be used as a specific safety endpoint, by measuring the Trans Epithelial Electrical Resistance (TEER), for the investigation of drug-induced GI toxicity. Compared to a widely used Caco-2 cell 2D Transwell model, the advanced MPS model (Mimetas OrganoPlate) allows for the recapitulation of the enterocyte cell layer of the intestinal barrier as the Caco-2 cells grow in a tubular structure through which the medium continuously flows. The OrganoPlate intestinal model was qualified to be implemented as a routine test system for the early prediction of drug-induced GI toxicity based on the measurement of the tightness of the cell layer by measuring changes in the TEER. For this qualification 23 well known compounds as well as a positive, negative and solvent control were selected. The compounds were selected based on their known effect on the GI system (chemotherapeutics, tight junction disruptor, liver toxins, controls, NSAIDs and a mixed group of drugs). The TEER values were measured 4h and 24h after treatment. In parallel the cell viability was determined after 24h to be able to distinguish between an unspecific cytotoxic effect or direct tight junction damage. Overall, from the 23 tested compounds, 15 showed the expected outcome, i.e.,the compound led to a decrease of the TEER for the positive control compounds, or the TEER value remained stable after treatment with non-GI-toxic compounds. In summary, this MPS model allowed the recapitulation of the human intestinal GI barrier and will enable a faster and more robust assessment of drug-induced damage in the GI tract.

Pharmacology and Toxicology

What problem does this paper attempt to address?

### Problems the Paper Aims to Solve

This paper aims to validate a gut cell culture model based on a microphysiological system (MPS) for assessing drug-induced toxicity. Specifically, the researchers used the advanced 3D cell culture system, Mimetas OrganoPlate®, to simulate the human intestinal barrier and evaluated the impact of drugs on intestinal barrier function by measuring changes in transepithelial electrical resistance (TEER).

#### Research Background and Objectives:
- **Limitations of Traditional Methods**: Traditional 2D cell culture models cannot fully replicate the in vivo environment, leading to lower accuracy in predicting drug toxicity.
- **Advantages of the New MPS Model**: MPS models can better simulate the in vivo environment, enhancing the physiological relevance and predictive capability of the model.
- **Application of Caco-2 Cells**: Caco-2 cells are widely used for studying drug-induced gastrointestinal toxicity due to their ability to form tight junctions.
- **Importance of TEER Measurement**: TEER values are an important indicator of cell barrier function and can be used to assess drug-induced damage to tight junctions.

#### Main Experimental Design:
- **Cell Culture**: Caco-2 cells are cultured in the Mimetas OrganoPlate® to form a 3D tubular structure.
- **Compound Screening**: A series of compounds known to affect the gastrointestinal system were selected for testing, including non-steroidal anti-inflammatory drugs (NSAIDs), chemotherapeutic agents, hepatotoxins, tight junction disruptors, and a mixed group of drugs.
- **TEER and Cell Viability Measurement**: TEER values and cell viability were measured at 4 hours and 24 hours post-treatment to distinguish between non-specific cytotoxicity and direct tight junction damage.

#### Results and Conclusions:
- **Positive Control**: Compounds known to disrupt tight junctions (e.g., staurosporine) were used as positive controls to validate the model's effectiveness.
- **Negative Control**: Drugs known to be non-toxic to the gastrointestinal system (e.g., metformin) were used as negative controls.
- **Drug Screening Results**: The results for most tested compounds were as expected, with toxic compounds causing a decrease in TEER values, while non-toxic compounds did not affect TEER values.
- **Model Advantages**: Compared to traditional 2D models, the Mimetas OrganoPlate® model can assess drug-induced gastrointestinal damage more quickly and accurately, offering higher predictive value.

In summary, the main objective of this paper is to improve the accuracy and efficiency of drug toxicity assessment by developing and validating a new MPS model.